OptiNose
OPTN
OPTN was delisted on the 20th of May, 2025.
71 hedge funds and large institutions have $127M invested in OptiNose in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 10 closing their positions.
76% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 17
0% less ownership
Funds ownership: 4.2% → 4.2% (-0%)
1% less funds holding
Funds holding: 72 → 71 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
40% less capital invested
Capital invested by funds: $212M → $127M (-$85.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$7.74M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.51M |
| 3 |
CCM
CAAS Capital Management
New York
|
+$1.92M |
| 4 |
TA
Tamarack Advisers
Carlsbad,
California
|
+$1.6M |
| 5 |
Walleye Capital
New York
|
+$1.48M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$1.04M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$998K |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$833K |
| 4 |
D.E. Shaw & Co
New York
|
-$795K |
| 5 |
Morgan Stanley
New York
|
-$614K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MIM
76
MetLife Investment Management
Whippany,
New Jersey
| – | -$119K | -1,070 | Closed |
|
|
AIM
77
Aigen Investment Management
New York
| – | -$100K | -894 | Closed |
|
|
MLICM
78
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$82.4K | -739 | Closed |
|
79
Russell Investments Group
London,
United Kingdom
| – | -$49K | -443 | Closed |
|
80
UBS Group
Zurich,
Switzerland
| – | -$37K | -334 | Closed |
|
OPTN Hedge Fund Activity: Q3 2020 in Review
71 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q3 2020, worth a combined $127M — down 40% from $212M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of OPTN and 9 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 30 added.
The largest buyer was Paradigm Capital Management Inc, adding an estimated $7.74M. The largest seller was Renaissance Technologies, cutting an estimated $1.04M.
- 71 institutional investors held OptiNose (OPTN) as of Q3 2020, down from 72 in Q2 2020.
- Funds reported $127M of OptiNose stock for Q3 2020, down 40% quarter-over-quarter.
- 9 funds opened new OptiNose positions in Q3 2020 and 10 closed out, a net change of -1 holder.
- The largest OptiNose buyer in Q3 2020 was Paradigm Capital Management Inc, an estimated $7.74M added.
- The largest OptiNose seller in Q3 2020 was Renaissance Technologies, an estimated $1.04M sold.
Based on aggregated 13F filings for Q3 2020.